| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |